NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 61 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $231,250 | -2.7% | 1,250,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $237,750 | -51.9% | 1,250,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $494,000 | -62.4% | 1,250,000 | 0.0% | 0.00% | -66.7% |
Q2 2022 | $1,313,000 | -44.1% | 1,250,000 | 0.0% | 0.01% | -33.3% |
Q1 2022 | $2,350,000 | -33.1% | 1,250,000 | 0.0% | 0.01% | -35.7% |
Q4 2021 | $3,513,000 | -22.2% | 1,250,000 | 0.0% | 0.01% | -30.0% |
Q3 2021 | $4,513,000 | -24.6% | 1,250,000 | 0.0% | 0.02% | -25.9% |
Q2 2021 | $5,988,000 | – | 1,250,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
CM Management, LLC | 370,000 | $389,000 | 0.41% |
Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |